Clavaseptin 62.5mg Palatable tablets for dogs and cats
Country: Ireland
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
07-02-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
amoxicillin 50 mg, clavulanic acid 12.5 mg
Available from:
Vetoquinol Uk limited
ATC code:
QJ01CR02
Pharmaceutical form:
Tablet
Therapeutic group:
amoxicillin and enzyme inhibitor
Therapeutic area:
Cats Non Food, Dogs Non Food
Authorization date:
2013-01-23
Summary of Product characteristics
Issued: April 2013
AN: 00043/2012
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
_ _
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
NAME
COUNTRIES
Clavaseptin 62.5 mg Palatable tablets for dogs
and cats
Belgium,
Bulgaria,
Cyprus,
Greece,
Czech
Republic,
Hungary,
Ireland,
Latvia,
Lithuania, Netherlands, Poland,
Romania, Slovakia, Slovenia,
UK, Portugal, Spain
Clavaseptin P 62.5 mg Tablets for dogs and cats
France, Luxembourg
Clavaseptin 62.5 mg
– Tablets for dogs and cats
Austria, Germany, Italy
Clavaseptin 50mg/12.5mg Tablets for dogs and
cats
Denmark,
Finland,
Sweden,
Norway
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains:
Active ingredients:
Amoxicillin (as amoxicillin trihydrate)……………….……………..………. 50.000 mg
Clavulanic acid (as potassium clavulanate)…………………………..…
12.500 mg
Excipients
Brown iron oxide (E172)………………………………….…..…….…..
0.120 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Beige scored tablet that can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
IN DOGS: treatment or adjunctive treatment of periodontal infections caused by
bacteria susceptible to amoxicillin in combination with clavulanic acid i.e. _Pasteurella _
spp, _Streptococcus_ spp and _Escherichia coli_.
IN CATS: treatment of skin infections (including wounds and abscesses) caused by
bacteria susceptible to amoxicillin in combination with clavulanic acid i
Read the complete document
